Europe edition, free version

View this email online 

 
 

The Wire

Private equity deal news and insights from the London newsroom

Feb 11, 2025

 

Archimed plans next diagnostics play; MidEuropa’s Diagnostyka IPO performs; US tariff winners and losers

Morning all, Craig McGlashan here with the Europe Wire from the London newsroom.

 

We double up on medical diagnostics this morning, first as Archimed’s Vincent Guillaumot talks us through his firm’s sale of Diesse and reveals plans for another play in the sector.

 

Next, we look at MidEuropa’s listing of Polish medical diagnostics services provider Diagnostyka as well as reports of Carlyle looking to list a chemicals business in the US. The ability of the European IPO market to offer exit routes this year was a subject we covered in depth yesterday.

 

We then consider potential winners and losers from the US government’s proposed tariffs, courtesy of comment from Datasite’s Merlin Piscitelli.

 

Finally, we’ve got a trio of GPs opening new offices: Tower Peak Partners, Inflexion and Adams Street Partners.

 

Expansion options

Archimed is eyeing another diagnostics company after selling Italian business Diesse for €125 million, managing partner Vincent Guillaumot told PE Hub’s Sophie Rose.

 

Read more, including how Archimed grew Diesse and where the firm sees further growth potential for the business, in the premium version of the Wire.

 

Going public

Sticking with diagnostic company exits, yesterday I wrote about how many GPs were skeptical about the European IPO market as a route to exit this year, with other options such as continuation vehicles and dividend recaps looking more attractive.

 

MidEuropa howeverlooks happy with the IPO market, after it listed its portfolio company Diagnostyka, a Krakow-headquartered medical diagnostic services provider,on the Warsaw Stock Exchange on Friday.

 

Read about the listing performance in the premium version of the Wire.

 

Another trend I looked at in the piece yesterday was GPs taking European companies to the US to list. It appears that Carlyle is following that route with Amsterdam-headquartered specialty chemicals producer Nouryon, with Bloomberg citing sources familiar with the matter that the GP has filed confidentially for a US IPO of the business. Carlyle declined to comment on the report when approached by PE Hub.

 

What’s your take on the European IPO market? Open for business or just for a few select names? Get in touch at [email protected]

 

Tariff talk

The US has announced a 25 percent import tax on all steel and aluminum, following an earlier announcement of 25 percent tariffs on goods from Canada and Mexico – since postponed – and an additional 10 percent tax on Chinese goods.

 

The tariff proposals could “significantly reshape the M&A landscape this year, creating both challenges and opportunities across sectors,”said Merlin Piscitelli, EMEA chief revenue officer at virtual data room provider Datasite, in a note seen by PE Hub.

 

Find out Piscitelli's views on which sectors stand to benefit and which strand to lose in the premium version of the Wire.

 

Location, location, location

A trio of private equity firms have opened new offices.

 

Read which and where in the premium version of the Wire.

 

We looked in depth at the advantages of having local offices in this roundup piece late last year.

 

That’s a wrap for me. Obey Martin Manayiti will write to you from the New York newsroom later today and I’ll be back with you from London tomorrow.

 

Cheers,

Craig

 

Read the full Wire commentary on PE Hub ...

Today's must reads

> Archimed to buy another European diagnostics company following Diesse exit More...
> Arctos-backed Hayfin MBO represents ‘trillion-dollar’ opportunity More...
> Kimmeridge's Neil McMahon: 'Demand for energy is only increasing' More...
> Who needs IPOs anyway? GPs eye M&A, CVs and dividend recaps More...
> Q4 2024 deals: Industrials and TMT led dealmaking More...

Also of note (may require subscriptions)

 

Trump restarts fight over carried interest: 'By raising its tax rate we would discourage capital formation, stifle innovation and ultimately reduce economic growth,' says Mahendra Ramsinghani of Secure Octane Investments. (Buyouts)

 

StepStone’s real estate secondaries fund surpasses predecessor by $1bn: StepStone Real Estate Partners V will focus on GP- and LP-led real estate deals in the US. (Secondaries)

 

Top placement agents see energy transition as central to fundraising in 2025: In 2025, LPs must engage with emerging managers and avoid 'strategy drift' as they opt for higher risk strategies. (Infrastructure Investor)

 

Cybersecurity threats and solutions evolve: Cybersecurity risks may be multiplying, but GPs are addressing them with innovation and rigor. (Private Funds CFO)

 

Regenerate AM launches €50m platform to convert Spanish farmland: The assets are currently planted with cereals and will be converted to a permanent crop operation that uses regenerative practices. (Agri Investor)

Deals

> Blackstone sells Anthos to Novartis for up to $3.1bn More...
> Goldman Sachs Alternatives to buy Trackunit from Hg and GRO Capital More...
> Main-backed Pro4all in fourth add-on deal with VeiligWerk More...
> Archimed to buy another European diagnostics company following Diesse exit More...
> Oval Partners-backed New Charter Technologies picks up Orchestrate AI More...
> Caymus Equity-backed Pan-Am Dental acquires JB Dental Lab and Avaneer Dental Studio More...
People
> Parthenon Capital-backed Medical Review Institute of America recruits Callahan as CEO More...
> Yellow Wood promotes Mandalap to principal More...
> Adams Street Partners opens new office in Toronto, hires Colin Miller More...

They said it

“I see many opportunities in diagnostics. It is a sector where there’s still many family-owned businesses, or entrepreneur-owned businesses that are not international enough. So we believe that, being a global investor like us, present in the US, Europe and Asia, we can open many markets for them.”

— Vincent Guillaumot, managing partner, Archimed

 

Today's letter was prepared by Craig McGlashan

Subscribe now to get full, unlimited access to all PE Hub content, including every PE Hub Wire article.

FIND OUT MORE
 

London | New York | Hong Kong | Tokyo | Sydney

PEI Group Ltd is registered in England no.6135779

Registered office: 5th Floor, 100 Wood Street, EC2V 7AN

LinkedInTwitter
 

To update your PE Hub email preferences, or to unsubscribe, click here.